Bharat Biotech has a stockpile of more than 50 million doses of COVAXIN ready to be distributed as required. Bharat Biotech has established COVAXIN manufacturing to reach an annualised capacity of 1 billion doses by the end of 2021.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wD8m1fW
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Covaxin safe and highly immunogenic in children 2-18 years : Lancet journal review
https://ift.tt/JEIex16
No comments:
Post a Comment